Literature DB >> 18363880

Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.

Christian Bogdan1.   

Abstract

Lifelong persistence after clinical cure of the primary infection is a characteristic feature of many intracellular pathogens, including viruses, bacteria and protozoa. The underlying mechanisms are complex and range from the passive protection against toxic effector molecules of the host and the remodelling of intracellular compartments as safe niches to the active modulation of the immune response at multiple levels. Parasites of the genus Leishmania have been particular helpful in unravelling some of the basic processes and form therefore the centre of the discussion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363880     DOI: 10.1111/j.1462-5822.2008.01146.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  46 in total

Review 1.  Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.

Authors:  Tony Wyss-Coray; Joseph Rogers
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.

Authors:  Siddhartha Kumar Bhaumik; Manoj Kumar Singh; Subir Karmakar; Tripti De
Journal:  Glycoconj J       Date:  2008-11-13       Impact factor: 2.916

3.  CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis.

Authors:  Suman Gupta; Shraddha A Sane; Nishi Shakya; Preeti Vishwakarma; W Haq
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

Review 4.  [Cutaneous leishmaniasis as travelers' disease. Clinical presentation, diagnostics and therapy].

Authors:  E von Stebut; U Schleicher; C Bogdan
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

5.  Characterization of the Protein Tyrosine Phosphatase LmPRL-1 Secreted by Leishmania major via the Exosome Pathway.

Authors:  Sabine Leitherer; Joachim Clos; Elisabeth M Liebler-Tenorio; Ulrike Schleicher; Christian Bogdan; Didier Soulat
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

6.  Visceral leishmaniasis with haemophagocytic lymphohistiocytosis.

Authors:  John Titus George; Mohammad Sadiq; Elanthenral Sigamani; Alice Joan Mathuram
Journal:  BMJ Case Rep       Date:  2019-02-13

7.  Functional proteome of macrophage carried nanoformulated antiretroviral therapy demonstrates enhanced particle carrying capacity.

Authors:  Andrea L Martinez-Skinner; Ram S Veerubhotla; Han Liu; Huangui Xiong; Fang Yu; JoEllyn M McMillan; Howard E Gendelman
Journal:  J Proteome Res       Date:  2013-04-17       Impact factor: 4.466

8.  The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation.

Authors:  Zhihe Kuang; Rowena S Lewis; Joan M Curtis; Yifan Zhan; Bernadette M Saunders; Jeffrey J Babon; Tatiana B Kolesnik; Andrew Low; Seth L Masters; Tracy A Willson; Lukasz Kedzierski; Shenggen Yao; Emanuela Handman; Raymond S Norton; Sandra E Nicholson
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

Review 9.  Caenorhabditis elegans meets microsporidia: the nematode killers from Paris.

Authors:  Jonathan Hodgkin; Frederick A Partridge
Journal:  PLoS Biol       Date:  2008-12-23       Impact factor: 8.029

Review 10.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.